Rights and permissions
About this article
Cite this article
Factor VIII costly, but still justified for haemophilia?. Pharmacoecon. Outcomes News 170, 7 (1998). https://doi.org/10.1007/BF03277637
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03277637